Alzheimer’s drug donanemab slows disease progression in global trial; Report Science July 18, 2023 United Kingdom: A new study has stated that the new drug donanemab will become a turning point in the fight…
Alzheimer’s drug Lecanemab hailed as a landmark breakthrough Home News November 30, 2022 Massachusetts: Lecanemab, the drug which is designed to target and clear amyloid, has become the first drug to slow the…
